PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $10,344,000 | +8.3% | 2,394,498 | 0.0% | 0.12% | +36.0% |
Q2 2019 | $9,554,000 | -25.6% | 2,394,498 | 0.0% | 0.09% | -20.4% |
Q1 2019 | $12,835,000 | +4.5% | 2,394,498 | 0.0% | 0.11% | +0.9% |
Q4 2018 | $12,284,000 | -47.1% | 2,394,498 | 0.0% | 0.11% | -39.9% |
Q3 2018 | $23,227,000 | -4.9% | 2,394,498 | 0.0% | 0.18% | -16.8% |
Q2 2018 | $24,424,000 | -21.5% | 2,394,498 | 0.0% | 0.21% | -28.7% |
Q1 2018 | $31,128,000 | -27.4% | 2,394,498 | 0.0% | 0.30% | -29.2% |
Q4 2017 | $42,862,000 | -28.7% | 2,394,498 | 0.0% | 0.42% | -43.4% |
Q3 2017 | $60,102,000 | +4.2% | 2,394,498 | 0.0% | 0.75% | +13.7% |
Q2 2017 | $57,707,000 | +46.6% | 2,394,498 | +17.1% | 0.66% | +42.3% |
Q1 2017 | $39,357,000 | +25.0% | 2,044,498 | 0.0% | 0.46% | +12.9% |
Q4 2016 | $31,485,000 | +18.4% | 2,044,498 | 0.0% | 0.41% | +8.5% |
Q3 2016 | $26,599,000 | -6.5% | 2,044,498 | 0.0% | 0.38% | -2.1% |
Q2 2016 | $28,439,000 | +21.4% | 2,044,498 | +32.4% | 0.39% | +14.2% |
Q1 2016 | $23,430,000 | -20.0% | 1,544,498 | 0.0% | 0.34% | -36.3% |
Q4 2015 | $29,299,000 | -0.2% | 1,544,498 | 0.0% | 0.53% | +8.6% |
Q3 2015 | $29,345,000 | -26.3% | 1,544,498 | 0.0% | 0.49% | -26.2% |
Q2 2015 | $39,802,000 | -26.6% | 1,544,498 | -11.0% | 0.66% | -27.2% |
Q1 2015 | $54,243,000 | -12.7% | 1,735,218 | 0.0% | 0.91% | -25.3% |
Q4 2014 | $62,100,000 | – | 1,735,218 | – | 1.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|